TPTX
TD Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-57,513
| Closed | -$1.54M | – | 1530 |
|
|
2022
Q1 | $1.54M | Sell |
57,513
-22,190
| -28% | -$596K | ﹤0.01% | 1160 |
|
|
2021
Q4 | $3.8M | Buy |
79,703
+23,094
| +41% | +$1.1M | ﹤0.01% | 947 |
|
|
2021
Q3 | $3.76M | Buy |
56,609
+5,600
| +11% | +$372K | ﹤0.01% | 902 |
|
|
2021
Q2 | $3.26M | Sell |
51,009
-1,151
| -2% | -$73.4K | ﹤0.01% | 943 |
|
|
2021
Q1 | $4.93M | Buy |
52,160
+4,119
| +9% | +$390K | 0.01% | 830 |
|
|
2020
Q4 | $5.85M | Buy |
48,041
+12,573
| +35% | +$1.53M | 0.01% | 749 |
|
|
2020
Q3 | $3.1M | Hold |
35,468
| – | – | ﹤0.01% | 823 |
|
|
2020
Q2 | $2.29M | Buy |
35,468
+5,664
| +19% | +$366K | ﹤0.01% | 846 |
|
|
2020
Q1 | $1.33M | Buy |
29,804
+3,200
| +12% | +$143K | ﹤0.01% | 925 |
|
|
2019
Q4 | $1.66M | Buy |
26,604
+3,325
| +14% | +$207K | ﹤0.01% | 970 |
|
|
2019
Q3 | $875K | Buy |
+23,279
| New | +$875K | ﹤0.01% | 1080 |
|